Meet the team

  • Dr. Edward Mena

    President, CEO, and principal investigator

    Dr. Mena has over 20 years of experience and is dedicated to further research on all aspects of liver disease, including better ways to diagnose and manage liver damage.

  • Stephanie Tang

    Chief Operations Officer

    Stephanie is responsible for managing all operational and business development aspects of CLRI. She enjoys working closely with the team to identify new opportunities and trials and to provide the best resources and options for patients with liver disease.

  • Iman Jomaa PA-C

    Sub-investigator

    Iman is a physician assistant and works with Dr. Mena to treat all patients with liver disease. She is focused on treating liver disease and has worked with Dr. Mena for several years, caring for and treating every patient that comes to the clinic.

  • Dr. Michel Mendler

    Chief Scientific Officer

    Dr. Michel Henry Mendler is a distinguished hepatologist with over thirty years of experience in clinical research, education, and patient care. As the chief scientific officer, he leads groundbreaking research initiatives focused on liver diseases.

Our mission

California Liver Research Institute is a non-profit organization focused on the advancement of treatment and management of liver disease. Our commitment is to expand and improve the knowledge of liver diseases and novel therapies, as well as to deliver quality patient care.

Pharmaceutical Companies

  • CLRI is a research facility that conducts clinical trials on liver disease.

  • On site, we have our own laboratory, storage space for frozen samples, centrifugation, and a FibroScan.

  • We pride ourselves in the experience of our professionals and the quality of care offered to our patients.

  • As a single center, the average time to start up a study is shorter, and you will get timely responses to your inquiries.

  • Dr. Edward Mena, a renowned hepatologist in Los Angeles county, is the president and CEO, as well as the principal investigator.

  • We conduct our own investigator’s initiative studies, to address different liver diseases affecting communities in LA.

“Over the course of the study, Dr. Mena and his team have exhibited exemplary collaboration with the sponsor and CRO team. From data management to recruitment, they are diligent, engaging, and proactive”

— Pfizer Newsletter